Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Anxiety and anxiety disorders in adults".)
International
●World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders (2022)
●WFSBP: Guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD (2022)
●World Health Organization (WHO): Guidelines on mental health promotive and preventive interventions for adolescents (2020)
●WHO: Guidelines for the management of conditions specifically related to stress (2013)
●WFSBP: Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care (2012)
Canada
●Canadian Paediatric Society (CPS): Position statement on promoting optimal mental health outcomes for children and youth (2023)
●CPS: Position statement on anxiety in children and youth – Part 1: Diagnosis (2022)
●CPS: Position statement on anxiety in children and youth – Part 2: The management of anxiety disorders (2022)
●CPS: Position statement on selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy – Infant and childhood outcomes (2021)
●Anxiety Disorders Association of Canada (ADAC): Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)
●Canadian Network for Mood and Anxiety Treatments (CANMAT): Task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders (2012)
United States
●US Preventive Services Task Force (USPSTF): Final recommendation statement on anxiety in children and adolescents – Screening (2022)
●American Academy of Child and Adolescent Psychiatry (AACAP): Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders (2020)
●American Academy of Pediatrics (AAP): Clinical report on providing psychosocial support to children and families in the aftermath of disasters and crises (2015, reaffirmed 2020)
●Women's Preventive Services Initiative (WPSI): Recommendation on screening for anxiety in adolescent and adult women (2020)
●AAP: Recognizing and referring children with posttraumatic stress disorder – Guidelines for pediatric providers (2018)
●AAP: Clinical report on clinical considerations related to the behavioral manifestations of child maltreatment (2017)
●AACAP: Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder (2010)
●American Psychiatric Association (APA): Practice guideline for the treatment of patients with panic disorder, 2nd edition (2009)
•APA: Treating panic disorder – A quick reference guide (2009)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Medical technologies guidance on Alpha-Stim AID for anxiety disorders (2021)
●NICE: Guideline on post-traumatic stress disorder (2018)
●NICE: Guideline on child abuse and neglect (2017)
●NICE: Guideline on children's attachment − Attachment in children and young people who are adopted from care, in care or at high risk of going into care (2015)
●British Association of Psychopharmacology (BAP): Guidelines for evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder (2005, revised 2014)
●NICE: Quality standard on anxiety disorders (2014)
●NICE: Clinical guideline on social anxiety disorder – Recognition, assessment and treatment (2013)
India
●Indian Psychiatric Society (IPS): Clinical practice guidelines for cognitive-behavioral therapies in anxiety disorders and obsessive-compulsive and related disorders (2020)
●IPS: Clinical practice guidelines for the management of generalised anxiety disorder (GAD) and panic disorder (PD) (2017)
Australia–New Zealand
●Phoenix Australia: Australian guidelines for the prevention and treatment of acute stress disorder, posttraumatic stress disorder and complex PTSD (2020, updated 2021)
•Complex PTSD
•General considerations when working with children and adolescents
•Specific populations and trauma types – Aboriginal and Torres Strait Islander peoples
•Specific populations and trauma types – Disasters
•Specific populations and trauma types – Motor vehicle accident and other traumatic injury survivors
•Specific populations and trauma types – Refugees and asylum seekers
•Specific populations and trauma types – Sexual assault
•Specific populations and trauma types – Terrorism
•Specific populations and trauma types – Victims of crime
•Specific populations and trauma types – Victims of intimate partner violence (IPV)
•Summary of interventions
•Trauma and trauma reactions
•Treatment recommendations
●Royal Australian and New Zealand College of Psychiatrists (RANZCP): Clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder (2018)
